vs
Esperion Therapeutics, Inc.（ESPR）与Natural Grocers by Vitamin Cottage, Inc.（NGVC）财务数据对比。点击上方公司名可切换其他公司
Natural Grocers by Vitamin Cottage, Inc.的季度营收约是Esperion Therapeutics, Inc.的2.0倍（$335.6M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 1.6%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs 4.4%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
Natural Grocers by Vitamin Cottage, Inc.是美国本土的特色零售连锁企业，主营认证有机食品、膳食补充剂、天然个护及环保家居类产品，面向健康意识较强的消费群体，门店覆盖美国多州，执行严格品控标准，拒绝售卖含人工添加剂的商品。
ESPR vs NGVC — 直观对比
营收规模更大
NGVC
是对方的2.0倍
$168.4M
营收增速更快
ESPR
高出142.1%
1.6%
两年增速更快
ESPR
近两年复合增速
4.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $335.6M |
| 净利润 | — | $11.3M |
| 毛利率 | — | 29.5% |
| 营业利润率 | 50.6% | 4.4% |
| 净利率 | — | 3.4% |
| 营收同比 | 143.7% | 1.6% |
| 净利润同比 | — | 14.0% |
| 每股收益（稀释后） | $0.32 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRNGVC
| Q4 25 | $168.4M | $335.6M | ||
| Q3 25 | $87.3M | $336.1M | ||
| Q2 25 | $82.4M | $328.7M | ||
| Q1 25 | $65.0M | $335.8M | ||
| Q4 24 | $69.1M | $330.2M | ||
| Q3 24 | $51.6M | $322.7M | ||
| Q2 24 | $73.8M | $309.1M | ||
| Q1 24 | $137.7M | $308.1M |
净利润ESPRNGVC
| Q4 25 | — | $11.3M | ||
| Q3 25 | $-31.3M | $11.8M | ||
| Q2 25 | $-12.7M | $11.6M | ||
| Q1 25 | $-40.5M | $13.1M | ||
| Q4 24 | — | $9.9M | ||
| Q3 24 | $-29.5M | $9.0M | ||
| Q2 24 | $-61.9M | $9.2M | ||
| Q1 24 | $61.0M | $8.0M |
毛利率ESPRNGVC
| Q4 25 | — | 29.5% | ||
| Q3 25 | — | 29.5% | ||
| Q2 25 | — | 29.9% | ||
| Q1 25 | — | 30.3% | ||
| Q4 24 | — | 29.9% | ||
| Q3 24 | — | 29.6% | ||
| Q2 24 | — | 29.2% | ||
| Q1 24 | — | 29.3% |
营业利润率ESPRNGVC
| Q4 25 | 50.6% | 4.4% | ||
| Q3 25 | -11.4% | 4.6% | ||
| Q2 25 | 8.6% | 4.7% | ||
| Q1 25 | -34.0% | 5.2% | ||
| Q4 24 | -6.4% | 4.0% | ||
| Q3 24 | -31.0% | 3.7% | ||
| Q2 24 | 3.5% | 4.2% | ||
| Q1 24 | 52.5% | 3.7% |
净利率ESPRNGVC
| Q4 25 | — | 3.4% | ||
| Q3 25 | -35.9% | 3.5% | ||
| Q2 25 | -15.4% | 3.5% | ||
| Q1 25 | -62.2% | 3.9% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | -57.2% | 2.8% | ||
| Q2 24 | -83.9% | 3.0% | ||
| Q1 24 | 44.3% | 2.6% |
每股收益（稀释后）ESPRNGVC
| Q4 25 | $0.32 | $0.49 | ||
| Q3 25 | $-0.16 | $0.51 | ||
| Q2 25 | $-0.06 | $0.50 | ||
| Q1 25 | $-0.21 | $0.56 | ||
| Q4 24 | $-0.14 | $0.43 | ||
| Q3 24 | $-0.15 | $0.38 | ||
| Q2 24 | $-0.33 | $0.40 | ||
| Q1 24 | $0.34 | $0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $23.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-302.0M | $220.0M |
| 总资产 | $465.9M | $668.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESPRNGVC
| Q4 25 | $167.9M | $23.2M | ||
| Q3 25 | $92.4M | $17.1M | ||
| Q2 25 | $86.1M | $13.2M | ||
| Q1 25 | $114.6M | $21.2M | ||
| Q4 24 | $144.8M | $6.3M | ||
| Q3 24 | $144.7M | $8.9M | ||
| Q2 24 | $189.3M | $13.9M | ||
| Q1 24 | $226.6M | $11.0M |
股东权益ESPRNGVC
| Q4 25 | $-302.0M | $220.0M | ||
| Q3 25 | $-451.4M | $212.4M | ||
| Q2 25 | $-433.5M | $202.5M | ||
| Q1 25 | $-426.2M | $193.0M | ||
| Q4 24 | $-388.7M | $181.9M | ||
| Q3 24 | $-370.2M | $174.3M | ||
| Q2 24 | $-344.2M | $167.8M | ||
| Q1 24 | $-294.3M | $160.0M |
总资产ESPRNGVC
| Q4 25 | $465.9M | $668.6M | ||
| Q3 25 | $364.0M | $670.5M | ||
| Q2 25 | $347.1M | $659.0M | ||
| Q1 25 | $324.0M | $664.6M | ||
| Q4 24 | $343.8M | $648.9M | ||
| Q3 24 | $314.1M | $655.5M | ||
| Q2 24 | $352.3M | $654.4M | ||
| Q1 24 | $373.1M | $656.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $21.1M |
| 自由现金流经营现金流 - 资本支出 | — | $11.6M |
| 自由现金流率自由现金流/营收 | — | 3.4% |
| 资本支出强度资本支出/营收 | 0.0% | 2.9% |
| 现金转化率经营现金流/净利润 | — | 1.86× |
| 过去12个月自由现金流最近4个季度 | — | $42.6M |
8季度趋势，按日历期对齐
经营现金流ESPRNGVC
| Q4 25 | $45.2M | $21.1M | ||
| Q3 25 | $-4.3M | $15.6M | ||
| Q2 25 | $-31.4M | $2.9M | ||
| Q1 25 | $-22.6M | $34.1M | ||
| Q4 24 | $-35.0M | $2.7M | ||
| Q3 24 | $-35.3M | $24.5M | ||
| Q2 24 | $-7.2M | $12.4M | ||
| Q1 24 | $53.8M | $20.2M |
自由现金流ESPRNGVC
| Q4 25 | — | $11.6M | ||
| Q3 25 | — | $7.5M | ||
| Q2 25 | — | $-4.2M | ||
| Q1 25 | — | $27.6M | ||
| Q4 24 | — | $-6.9M | ||
| Q3 24 | $-35.5M | $18.0M | ||
| Q2 24 | $-7.3M | $3.6M | ||
| Q1 24 | $53.8M | $9.8M |
自由现金流率ESPRNGVC
| Q4 25 | — | 3.4% | ||
| Q3 25 | — | 2.2% | ||
| Q2 25 | — | -1.3% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | -2.1% | ||
| Q3 24 | -68.7% | 5.6% | ||
| Q2 24 | -9.9% | 1.2% | ||
| Q1 24 | 39.0% | 3.2% |
资本支出强度ESPRNGVC
| Q4 25 | 0.0% | 2.9% | ||
| Q3 25 | 0.0% | 2.4% | ||
| Q2 25 | 0.0% | 2.2% | ||
| Q1 25 | 0.0% | 1.9% | ||
| Q4 24 | 0.0% | 2.9% | ||
| Q3 24 | 0.3% | 2.0% | ||
| Q2 24 | 0.1% | 2.9% | ||
| Q1 24 | 0.1% | 3.4% |
现金转化率ESPRNGVC
| Q4 25 | — | 1.86× | ||
| Q3 25 | — | 1.32× | ||
| Q2 25 | — | 0.25× | ||
| Q1 25 | — | 2.60× | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | 2.72× | ||
| Q2 24 | — | 1.35× | ||
| Q1 24 | 0.88× | 2.54× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
NGVC
| Grocery | $243.8M | 73% |
| Dietary Supplements | $60.7M | 18% |
| Manufactured Product Other | $31.0M | 9% |
